A Population‐Based Approach to Reporting System–Level Performance Measures for Rheumatoid Arthritis Care-Reference-Cited by-同舟云学术

A Population‐Based Approach to Reporting System–Level Performance Measures for Rheumatoid Arthritis Care

Published:2021-05 Issue:5 Volume:73 Page:640-648
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Barber Claire E. H.¹^ORCID,Marshall Deborah A.¹^ORCID,Szefer Elena²,Barnabe Cheryl¹^ORCID,Shiff Natalie J.³,Bykerk Vivian⁴,Homik Joanne⁵,Thorne J. Carter⁶,Ahluwalia Vandana⁷,Benseler Susanne⁸,Mosher Dianne⁹,Twilt Marinka⁸,Lacaille Diane¹⁰^ORCID

Affiliation:

1. University of Calgary, Calgary, Alberta, Canada, and Arthritis Research Canada Richmond British Columbia Canada

2. Emmes Canada Burnaby British Columbia Canada

3. University of Saskatchewan Saskatoon Saskatchewan Canada

4. Hospital for Special Surgery and Cornell University New York New York

5. University of Alberta Edmonton Alberta Canada

6. Southlake Regional Health Care Newmarket Ontario Canada

7. William Osler Health System Brampton Ontario Canada

8. Alberta Children’s Hospital University of Calgary Calgary Alberta Canada

9. University of Calgary Calgary Alberta Canada

10. Arthritis Research Canada, Richmond, and University of British Columbia Vancouver British Columbia Canada

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24178

Reference26 articles.

1. CDDSS Arthritis Working Group. National Surveillance of Arthritis in Canada, results from the Canadian Chronic Disease Surveillance System (CCDSS) [abstract];O’Donnell S;J Rheumatol,2019

2. Public Health Agency of Canada.Canadian Chronic Disease Surveillance System (CCDSS).2018. URL:https://infobase.phac-aspc.gc.ca/CCDSS-SCSMC/data-tool/.

3. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

4. Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs

5. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A population-based analysis of rheumatology care patterns for inflammatory arthritis during COVID-19 in Alberta, Canada;Seminars in Arthritis and Rheumatism;2024-04

2. A scoping review of shared care models for rheumatoid arthritis with patient-initiated follow-up;Seminars in Arthritis and Rheumatism;2023-06

3. Researchers in rheumatology should avoid categorization of continuous predictor variables;BMC Medical Research Methodology;2023-04-26

4. Investigating Associations Between Access to Rheumatology Care, Treatment, Continuous Care, and Healthcare Utilization and Costs Among Older Individuals With Rheumatoid Arthritis;The Journal of Rheumatology;2023-01-15

5. System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019;BMC Rheumatology;2022-12-27